1. 1567Simplification to elvitegravir/cobicistat/emtricitabine/tenofovir DF from ritonavir-boosted protease inhibitor plus emtricitabine/tenofovir DF maintains HIV suppression and improves fasting triglycerides at week 48. (December 2014) Authors: Cunningham, Douglas; Shamblaw, David; Zurawski, Christine; Robbins, William; Scarsella, Anthony; Nguyen, Thai; Hindman, Jason; Ebrahimi, Ramin; Piontkowsky, David Journal: Open forum infectious diseases Issue: Volume 1(2014)Supplement 1 Page Start: S417 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. 1768. Efficacy and Safety of Switching From Boosted-Protease Inhibitors (bPI) Plus Emtricitabine/Tenofovir Disoproxil Fumarate (F/TDF) Regimens to the Once Daily (QD), Single-Tablet Regimen (STR) of Darunavir/Cobicistat/Emtricitabine/Tenofovir Alafenamide (D/C/F/TAF) in Virologically Suppressed, HIV-1-Infected Adults: Week 96 Results of the Phase 3, Randomized, Non-Inferiority EMERALD Trial. (26th November 2018) Authors: Eron, Joseph; Orkin, Chloe; Cunningham, Douglas; Pulido, Federcio; Post, Frank; De Wit, Stéphane; Lathouwers, Erkki; Hufkens, Veerle; Petrovic, Romana; Van Landuyt, Erika Journal: Open forum infectious diseases Issue: Volume 5(2018)Supplement 1 Page Start: S65 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. A Survey of Perceptually Motivated 3D Visualization of Medical Image Data. (4th July 2016) Authors: Preim, Bernhard; Baer, Alexandra; Cunningham, Douglas; Isenberg, Tobias; Ropinski, Timo Journal: Computer graphics forum Issue: Volume 35:Number 3(2016) Page Start: 501 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗